Lack of a relationship between plasma PCSK9 concentrations and hepatic lipoprotein kinetics in obese people
- 30 November 2011
- journal article
- Published by Elsevier in Translational Research
- Vol. 158 (5) , 302-306
- https://doi.org/10.1016/j.trsl.2011.06.006
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver diseaseInternational Journal of Obesity, 2010
- Genetic and Metabolic Determinants of Plasma PCSK9 LevelsJournal of Clinical Endocrinology & Metabolism, 2009
- PCSK9: a convertase that coordinates LDL catabolismJournal of Lipid Research, 2009
- The LDL ReceptorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Plasma PCSK9 preferentially reduces liver LDL receptors in miceJournal of Lipid Research, 2008
- Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver DiseaseGastroenterology, 2008
- Molecular biology of PCSK9: its role in LDL metabolismTrends in Biochemical Sciences, 2007
- Molecular Characterization of Loss-of-Function Mutations in PCSK9 and Identification of a Compound HeterozygoteAmerican Journal of Human Genetics, 2006
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Novel mutations of thePCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemiaHuman Mutation, 2005